Clinical Outcomes of First-line Therapies for Advanced Non–Small Cell Lung Cancer A Systematic Review of Trials Published Between 2010 and 2020
Objectives: To analyze the evolution of clinical outcomes derived from clinical trials on first-line therapies for advanced or metastatic non–small cell lung cancer (NSCLC) published between 2010 and 2020, focusing on how these outcomes impact survival rates and management of patients. Methods: A systematic review of phase III and pivotal phase II clinical trials was…